Civil procedure: civil actions; civil actions against certain opioid litigation settlement defendants; prohibit. Amends secs. 2 & 3 of 2022 PA 85 (MCL 691.1672 & 691.1673).
Impact
The bill's impact on state laws is significant as it explicitly limits the ability of local government entities, such as cities and counties, to pursue legal action against certain pharmaceutical companies involved in the opioid crisis after specific cutoff dates. By doing this, SB0616 aims to resolve uncertainties regarding ongoing and future litigation concerning opioids, reinforcing the finality of the settlements reached with various companies. This may lead to reduced legal exposure for these entities, promoting a more structured path toward recovery from the opioid crisis without further legal hindrance.
Summary
Senate Bill 616 (SB0616) aims to amend the Opioid Liability Litigation Act by introducing new provisions that prohibit certain political subdivisions from initiating legal actions related to opioid litigation settlements after specified dates. Specifically, the bill sets a timeline for when actions related to various settlements with pharmaceutical companies can no longer be brought forth, effectively preventing future litigation concerning claims that fall under these settlements. This approach seeks to provide legal clarity and stability regarding opioid-related claims in Michigan.
Sentiment
The sentiment surrounding SB0616 appears to be mixed. Supporters argue that the bill is a necessary measure to protect the interests of the state and local governments by establishing clear legal boundaries following substantial settlements. They believe it encourages compliance with these settlements by reducing the potential for protracted litigation. Conversely, critics express concern that the bill might unduly restrict local governments from addressing ongoing public health issues related to opioids, making it difficult for communities to seek justice or compensation for damages incurred due to the opioid epidemic.
Contention
A point of contention regarding SB0616 is its approach towards limiting the avenues for legal recourse available to local governments. Some lawmakers and advocacy groups fear that by eliminating the ability to sue related entities after specific dates, the bill undermines local autonomy and public health efforts. Opponents argue that additional legal action may still be needed in response to persistent challenges posed by the opioid crisis, indicating a debate on balancing legal restrictions with community health needs.
Civil procedure: civil actions; immunity from civil action for individual who uses force in compliance with self-defense act; provide for. Amends secs. 2922b & 2922c of 1961 PA 236 (MCL 600.2922b & 600.2922c).
Civil procedure: civil actions; immunity from civil action for individual who uses force in compliance with self-defense act; provide for. Amends secs. 2922b & 2922c of 1961 PA 236 (MCL 600.2922b & 600.2922c).
Civil procedure: civil actions; action for medical monitoring for individuals exposed to a proven toxic substance; provide for. Amends secs. 20126 & 20140 of 1994 PA 451 (MCL 324.20126 & 324.20140) & adds sec. 20136.
Provides for a public Settlement Agreement Information Database to contain certain information regarding settlements entered into by state agencies (EG NO IMPACT See Note)